AnPac Bio’s To start with Condition Procedure Patent Granted, and Its Most cancers Procedure Task Secured Multi-Million Dollar Funds

PHILADELPHIA, June 18, 2021 (Globe NEWSWIRE) — AnPac Bio-Professional medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology firm with functions in China and the United States centered on early cancer screening and detection as well as most cancers treatment, declared currently that it has been granted its initially disorder procedure patent by the United States Patent and Trademark Place of work on June 7, 2021. The patent addresses novel professional medical equipment for both equally condition detection and cure applications and has 25 promises. This patent covers novel device buildings and strategies to modify

Read more